Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 964012, 11 pages
http://dx.doi.org/10.1155/2013/964012
Research Article

Novel Biphasic Role of Resolvin D1 on Expression of Cyclooxygenase-2 in Lipopolysaccharide-Stimulated Lung Fibroblasts Is Partly through PI3K/AKT and ERK2 Pathways

1Department of Anesthesia and Critical Care, Second Affiliated Hospital of Wenzhou Medical University, 109 Xueyuan Road, Wenzhou, Zhejiang Province 325027, China
2Academic Department of Anesthesia, Critical Care, Pain and Resuscitation, Birmingham Heartlands Hospital, Heart of England NHS Foundation Trust, Birmingham B9 5SS, UK

Received 1 April 2013; Revised 28 June 2013; Accepted 18 July 2013

Academic Editor: Tânia Fröde

Copyright © 2013 Derong Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Pugin, G. Verghese, M. Widmer, and M. A. Matthay, “The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome,” Critical Care Medicine, vol. 27, no. 2, pp. 304–312, 1999. View at Google Scholar · View at Scopus
  2. L. B. Ware and M. A. Matthay, “Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 282, no. 5, pp. L924–L940, 2002. View at Google Scholar · View at Scopus
  3. C. D. Buckley, “Why does chronic inflammation persist: an unexpected role for fibroblasts,” Immunology Letters, vol. 138, no. 1, pp. 12–14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Quesnel, S. Marchand-Adam, A. Fabre et al., “Regulation of hepatocyte growth factor secretion by fibroblasts in patients with acute lung injury,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 294, no. 2, pp. L334–L343, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Selige, H. Tenor, A. Hatzelmann, and T. Dunkern, “Cytokine-dependent balance of mitogenic effects in primary human lung fibroblasts related to cyclic AMP signaling and phosphodiesterase 4 inhibition,” Journal of Cellular Physiology, vol. 223, no. 2, pp. 317–326, 2010. View at Google Scholar
  6. R. S. Smith, T. J. Smith, T. M. Blieden, and R. P. Phipps, “Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation,” The American Journal of Pathology, vol. 151, no. 2, pp. 317–322, 1997. View at Google Scholar · View at Scopus
  7. R. P. Marshall, S. Webb, G. J. Bellingan et al., “Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome,” The American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 5, pp. 646–650, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. R. P. Marshall, G. Bellingan, S. Webb et al., “Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome,” The American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 5, pp. 1783–1788, 2000. View at Google Scholar · View at Scopus
  9. C. N. Serhan, S. D. Brain, C. D. Buckley et al., “Resolution of inflammation: state of the art, definitions and terms,” FASEB Journal, vol. 21, no. 2, pp. 325–332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Andersson-Sjoland, K. Nihlberg, L. Eriksson, L. Bjermer, and G. Westergren-Thorsson, “Fibrocytes and the tissue niche in lung repair,” Respiratory Research, vol. 12, article 76, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Qu, X. Zhang, J. Yao, J. Song, D. J. Nikolic-Paterson, and J. Li, “Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation,” Journal of Pathology, vol. 228, pp. 506–519, 2012. View at Google Scholar
  12. L. B. Ware and M. A. Matthay, “The acute respiratory distress syndrome,” The New England Journal of Medicine, vol. 342, no. 18, pp. 1334–1349, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Botting and S. S. Ayoub, “COX-3 and the mechanism of action of para-cetamol/acetaminophen,” Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 72, no. 2, pp. 85–87, 2005. View at Publisher · View at Google Scholar
  14. C. Y. Wu, P. L. Chi, H. L. Hsieh, S. F. Luo, and C. M. Yang, “TLR4-dependent induction of vascular adhesion molecule-1 in rheumatoid arthritis synovial fibroblasts: roles of cytosolic phospholipase a 2α/cyclooxygenase-2,” Journal of Cellular Physiology, vol. 223, no. 2, pp. 480–491, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. A. D. Mancini and J. A. Di Battista, “The cardinal role of the phospholipase A2/cyclooxygenase-2/prostaglandin E synthase/prostaglandin E2 (PCPP) axis in inflammostasis,” Inflammation Research, vol. 60, no. 12, pp. 1083–1092, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Vong, J. G. P. Ferraz, R. Panaccione, P. L. Beck, and J. L. Wallace, “A pro-resolution mediator, prostaglandin D2, is specifically up-regulated in individuals in long-term remission from ulcerative colitis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 26, pp. 12023–12027, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. C. N. Serhan, S. Hong, K. Gronert et al., “Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals,” Journal of Experimental Medicine, vol. 196, no. 8, pp. 1025–1037, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Krishnamoorthy, A. Recchiuti, N. Chiang et al., “Resolvin D1 binds human phagocytes with evidence for proresolving receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 4, pp. 1660–1665, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. L. V. Norling, J. Dalli, R. J. Flower, C. N. Serhan, and M. Perretti, “Resolvin D1 limits polymorphonuclear leukocytes recruitment to inflammatory loci: receptor-dependent actions,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 8, pp. 1970–1978, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. P. Sun, S. F. Oh, J. Uddin et al., “Resolvin D1 and its aspirin-triggered 17R epimer: stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation,” The Journal of Biological Chemistry, vol. 282, no. 13, pp. 9323–9334, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. J. S. Duffield, S. Hong, V. S. Vaidya et al., “Resolvin D series and protectin D1 mitigate acute kidney injury,” Journal of Immunology, vol. 177, no. 9, pp. 5902–5911, 2006. View at Google Scholar · View at Scopus
  22. A. Recchiuti, S. Krishnamoorthy, G. Fredman, N. Chiang, and C. N. Serhan, “MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits,” FASEB Journal, vol. 25, no. 2, pp. 544–560, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Tian, Y. Lu, A. M. Sherwood, D. Hongqian, and S. Hong, “Resolvins el and dl in choroid-retinal endothelial cells and leukocytes: biosynthesis and mechanisms of anti-inflammatory actions,” Investigative Ophthalmology and Visual Science, vol. 50, no. 8, pp. 3613–3620, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Kasuga, R. Yang, T. F. Porter et al., “Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution,” Journal of Immunology, vol. 181, no. 12, pp. 8677–8687, 2008. View at Google Scholar · View at Scopus
  25. B. Wang, X. Gong, J. Wan et al., “Resolvin D1 protects mice from LPS-induced acute lung injury,” Pulmonary Pharmacology and Therapeutics, vol. 24, no. 4, pp. 434–441, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Fukunaga, P. Kohli, C. Bonnans, L. E. Fredenburgh, and B. D. Levy, “Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury,” Journal of Immunology, vol. 174, no. 8, pp. 5033–5039, 2005. View at Google Scholar · View at Scopus
  27. C. Bonnans, K. Fukunaga, M. A. Levy, and B. D. Levy, “Lipoxin A4 regulates bronchial epithelial cell responses to acid injury,” The American Journal of Pathology, vol. 168, no. 4, pp. 1064–1072, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. J. C. Bonner, A. B. Rice, J. L. Ingram et al., “Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis,” The American Journal of Pathology, vol. 161, no. 2, pp. 459–470, 2002. View at Google Scholar · View at Scopus
  29. E. A. Meade, W. L. Smith, and D. L. DeWitt, “Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs,” The Journal of Biological Chemistry, vol. 268, no. 9, pp. 6610–6614, 1993. View at Google Scholar · View at Scopus
  30. X. M. Tong, J. C. Wang, Y. Shen, J. Xie, J. J. Zhang, and J. Y. Jin, “Inhibition of inflammatory mediators and related signaling pathways by macrophage-stimulating protein in rheumatoid arthritis synovial fibroblasts,” Inflammation Research, vol. 60, no. 9, pp. 823–829, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. X. Li, J. C. Tupper, D. D. Bannerman, R. K. Winn, C. J. Rhodes, and J. M. Harlan, “Phosphoinositide 3 kinase mediates toll-like receptor 4-induced activation of NF-κB in endothelial cells,” Infection and Immunity, vol. 71, no. 8, pp. 4414–4420, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. J. I. Sznajder, “Alveolar edema must be cleared for the acute respiratory distress syndrome patient to survive,” The American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 6, pp. 1293–1294, 2001. View at Google Scholar · View at Scopus
  33. G. D. Perkins, D. F. McAuley, D. R. Thickett, and F. Gao, “The β-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial,” The American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 3, pp. 281–287, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. F. G. Smith, G. D. Perkins, S. Gates et al., “Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial,” The Lancet, vol. 379, no. 9812, pp. 229–235, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Spite, L. Summers, T. F. Porter, S. Srivastava, A. Bhatnagar, and C. N. Serhan, “Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress,” The British Journal of Pharmacology, vol. 158, no. 4, pp. 1062–1073, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. C. A. Hudert, K. H. Weylandt, Y. Lu et al., “Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 30, pp. 11276–11281, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. J. E. Gadek, S. J. DeMichele, M. D. Karlstad et al., “Enteral nutrition with eicosapentaenoic acid (EPA), γ-linolenic acid (GLA) and antioxidants reduces pulmonary inflammation and new organ failures in patients with acute respiratory distress syndrome. Enteral nutrition in ARDS study group,” Critical Care Medicine, vol. 27, no. 8, pp. 1409–1420, 1999. View at Google Scholar
  38. C. Quesnel, L. Nardelli, P. Piednoir et al., “Alveolar fibroblasts in acute lung injury: biological behaviour and clinical relevance,” European Respiratory Journal, vol. 35, no. 6, pp. 1312–1321, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. D. W. Gilroy, P. R. Colville-Nash, D. Willis, J. Chivers, M. J. Paul-Clark, and D. A. Willoughby, “Inducible cyclooxygenase may have anti-inflammatory properties,” Nature Medicine, vol. 5, no. 6, pp. 698–701, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. E. A. Meade, W. L. Smith, and D. L. DeWitt, “Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs,” The Journal of Biological Chemistry, vol. 268, no. 9, pp. 6610–6614, 1993. View at Google Scholar · View at Scopus
  41. R. Rajakariar, M. M. Yaqoob, and D. W. Gilroy, “COX-2 in inflammation and resolution,” Molecular Interventions, vol. 6, no. 4, pp. 199–207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. S. G. Morham, R. Langenbach, C. D. Loftin et al., “Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse,” Cell, vol. 83, no. 3, pp. 473–482, 1995. View at Google Scholar · View at Scopus
  43. J. N. Dai, Y. Zong, L. M. Zhong et al., “Gastrodin inhibits expression of inducible no synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-Stimulated microglia via MAPK pathways,” PLoS ONE, vol. 6, no. 7, Article ID e21891, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. W. J. Frazier, X. Wang, L. M. Wancket et al., “Increased inflammation, impaired bacterial clearance, and metabolic disruption after gram-negative sepsis in Mkp-1-deficient mice,” Journal of Immunology, vol. 183, no. 11, pp. 7411–7419, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. W. J. Zhang, H. Wei, T. Hagen, and B. Frei, “α-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 10, pp. 4077–4082, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Q. Xu, B. J. Liu, J. F. Wu et al., “Icariin attenuates LPS-induced acute inflammatory responses: involvement of PI3K/Akt and NFκB signaling pathway,” European Journal of Pharmacology, vol. 642, no. 1–3, pp. 146–153, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Mebratu and Y. Tesfaigzi, “How ERK1/2 activation controls cell proliferation and cell death is subcellular localization the answer?” Cell Cycle, vol. 8, no. 8, pp. 1168–1175, 2009. View at Google Scholar · View at Scopus
  48. C. Vantaggiato, I. Formentini, A. Bondanza, C. Bonini, L. Naldini, and R. Brambilla, “ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially,” Journal of Biology, vol. 5, article 14, 2006. View at Publisher · View at Google Scholar · View at Scopus